We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Aspect Medical Systems (MM) | NASDAQ:ASPM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.27 | 0 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [_]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[_] Preliminary Proxy Statement
[_] Confidential, for Use of the Commission Only (as permitted
by Rule 14a-6(e)(2))
[_] Definitive Proxy Statement
[_] Definitive Additional Materials
[X] Soliciting Material Pursuant to ss.240.14a-12
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
[_] Fee paid previously with preliminary materials:
On March 12, 2009, representatives of First BioMed, L.P. delivered a notice (the "Notice") to Mr. J. Neal Armstrong, the Vice President, Chief Financial Officer and Secretary of Aspect Medical Systems, Inc. (the "Company"), in accordance with Section 1.10 and Section 1.11 of the Amended and Restated Bylaws of the Company (the "Bylaws"). In the Notice, the Stockholder (i) nominated Jon C. Biro, Melvin L. Keating and Vincent P. Scialli for election to the Company's Board of Directors at the Company's 2009 annual meeting of stockholders and stated that it intends to reaffirm those nominations at such annual meeting and (ii) proposed that the Company's stockholders approve resolutions (A) recommending that the Board of Directors form a special committee of independent directors to study ways to optimize the Company's capital structure and otherwise maximize stockholder value and (B) to amend the Company's Bylaws to require that the annual meeting be held no later than May 21 in each year.
SECURITY HOLDERS ARE ADVISED TO READ THE PROXY STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION OF PROXIES BY OR ON BEHALF OF FIRST BIOMED, L.P. AND CERTAIN OF ITS AFFILIATES FROM THE STOCKHOLDERS OF ASPECT MEDICAL SYSTEMS, INC. FOR USE AT ITS ANNUAL MEETING WHEN AND IF THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO THE PARTICIPANTS IN ANY SUCH PROXY SOLICITATION. WHEN AND IF COMPLETED, A DEFINITIVE PROXY STATEMENT AND A FORM OF PROXY WILL BE MADE AVAILABLE TO THE STOCKHOLDERS OF ASPECT MEDICAL SYSTEMS, INC. FROM THE PARTICIPANTS AT NO CHARGE AND WILL ALSO BE AVAILABLE AT NO CHARGE AT THE SECURITIES AND EXCHANGE COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV. INFORMATION RELATING TO THE POTENTIAL PARTICIPANTS IN THE POTENTIAL PROXY SOLICITATION IS CONTAINED IN ANNEX 1 ATTACHED HERETO AND IS INCORPORATED HEREIN BY REFERENCE.
ANNEX 1
POTENTIAL PARTICIPANTS
The potential participants in the solicitation (the "Solicitation") of proxies from the stockholders of Aspect Medical Systems, Inc. (the "Company") may include the following: (i) First BioMed, L.P., a New York limited partnership ("First BioMed"), (ii) First Manhattan Co., a New York limited partnership ("FMC"), (iii) Samuel F. Colin, Neal K. Stearns and Anthony Avicolli, each as an employee of FMC, and (iv) Jon C. Biro, Melvin L. Keating and Vincent P. Scialli, each as a nominee for election as a director (collectively, the "Nominees").
First BioMed is principally engaged in the business of investing in securities. First BioMed's business address is 437 Madison Avenue, New York, New York 10022. First BioMed is the holder of record of 1,000 shares and the economic owner of 863,364 shares of common stock, $0.01 par value per share ("Common Stock"), of the Company. However, First BioMed does not beneficially own any shares of Common Stock within the meaning of Section 13(d) of the Securities Exchange Act of 1934 and the rules thereunder.
FMC is registered as a broker-dealer under the Securities Exchange Act of 1934 and as an investment adviser under the Investment Advisers Act of 1940, and its principal business is investment management. The sole general partner of FMC is First Manhattan LLC, a New York limited liability company. FMC's business address is 437 Madison Avenue, New York, New York 10022. FMC serves as investment adviser to First Health, L.P., First Health Limited and First Health Associates, L.P. (collectively, the "First Health Funds"). First Health, L.P., First Health Limited and First Health Associates, L.P. presently hold 580,191, 355,500 and 74,700 shares, respectively, of Common Stock in their accounts. FMC and Dr. Samuel F. Colin are the Co-Managing Members of First BioMed Management Associates, LLC, a Delaware limited liability company ("FBMA"). FBMA is registered as an investment adviser under the Investment Advisers Act of 1940, and its principal business is investment management. FBMA serves as investment adviser to First BioMed and First BioMed Portfolio, L.P. (collectively, the "First BioMed Funds", and collectively with the First Health Funds, the "First Manhattan Funds"). First BioMed and First BioMed Portfolio, L.P. presently hold 863,364 and 487,815 shares, respectively, of Common Stock in their accounts. By virtue of its role as investment adviser to the First Health Funds and as a Co-Managing Member of FBMA, FMC may be deemed to be a beneficial owner of 2,361,570 shares of Common Stock held for the accounts of the First Manhattan Funds. The business address of each of the First Manhattan Funds is 437 Madison Avenue, New York, New York 10022. Information concerning shares of Common Stock purchased within the last two years for the accounts of any of the First Manhattan Funds is contained in Annex 2 and is incorporated herein by reference.
Dr. Samuel F. Colin is a Senior Managing Director and a limited partner of FMC, and his principal business is acting as portfolio manager for the First Manhattan Funds. Dr. Colin's business address is 437 Madison Avenue, New York, New York
10022. By virtue of his role as portfolio manager of the First Manhattan Funds, Dr. Colin may be deemed to be a beneficial owner of 2,361,570 shares of the Common Stock held for the accounts of the First Manhattan Funds. Information concerning shares of Common Stock purchased within the last two years for the accounts of any of the First Manhattan Funds is contained in Annex 2 and is incorporated herein by reference.
Neal K. Stearns is a Senior Managing Director of FMC and his business address is 437 Madison Avenue, New York, New York 10022.
Anthony Avicolli is a Managing Director of FMC and his business address is 437 Madison Avenue, New York, New York 10022.
Jon C. Biro currently is the Executive Vice President and Chief Financial and Accounting Officer and serves as a director of Consolidated Graphics, Inc. (a web- and digital-based commercial printing company, the principal business address of which is 5858 Westheimer, Suite 200, Houston, TX 77057 (NYSE: CGX)). Until 2008, Mr. Biro was the Chief Financial Officer and served as a director of ICO, Inc. (a polymer production company, the principal business address of which is 1811 Bering Drive, Suite 200, Houston, TX 77057 (NASDAQ: ICOC)). Mr. Biro's business address is 5858 Westheimer, Suite 200, Houston, TX 77057.
Melvin L. Keating currently serves as a director and member of the Audit, Compensation and Finance Committees of LCC International, Inc. (a wireless engineering company, the principal business address of which is 7900 Westpark Drive Suite A-315, McLean, VA 22102 (OTC: LCCI)) and as a director and member of the Operations and Audit Committees of White Electronic Designs Corporation (an electronics and semiconductor manufacturing company, the principal business address of which is 3601 East University Drive, Phoenix, AZ 85034 (NASDAQ: WEDC)). From October 2005 to September 2008, Mr. Keating was the President and CEO of Alliance Semiconductor Corporation (a holding company, the principal business address of which is 4633 Old Ironsides Dr, #240, Santa Clara, CA 95054 (OTC: ALSC)), and from April 2004 to September 2005, Mr. Keating was the Executive Vice President, CFO and Treasurer of Quovadx Inc. (a healthcare software and services company now known as Healthvision, the principal business address of which is 5030 Riverside Drive, Suite 300, Irving, TX 75039). Mr. Keating's business address is 18 Driftwood Dr., Livingston, NJ 07039.
Vincent P. Scialli currently is a Managing Director of FMC. From May 2001 to February 2005, Mr. Scialli was employed at Lord Abbett & Co. LLC (an investment management company, the principal business address of which is 90 Hudson Street, Jersey City, NJ 07302), at which his last role was as Vice President and Assistant Portfolio Manager. Mr. Scialli beneficially owns 2,000 shares of the Common Stock, which were purchased by Mr. Scialli on July 24, 2008 for a consideration of $6.9455 per share. Mr. Scialli's business address is 437 Madison Avenue, New York, New York 10022.
FMC has agreed to indemnify the Nominees for certain losses, if any, arising from their participation in the solicitation of proxies from the stockholders of the Company in connection with the election of directors at the Company's annual meeting of stockholders to be held in 2009 and to reimburse them for their reasonable out-of-pocket expenses in connection therewith.
ANNEX 2
INFORMATION CONCERNING SHARES OF COMMON STOCK OF THE
COMPANY PURCHASED WITHIN THE LAST TWO YEARS FOR THE
ACCOUNTS OF ANY OF THE FIRST MANHATTAN FUNDS
FIRST HEALTH ASSOCIATES, L.P.
Date Shares Cost/Unit Total Cost ---- ------ --------- ---------- 6/20/07 8,100 15.48 125,423.64 6/21/07 8,100 15.25 123,545.25 6/25/07 1,000 14.96 14,955.25 6/26/07 1,700 14.95 25,421.29 6/27/07 1,600 14.88 23,804.16 6/29/07 2,400 15.04 36,091.20 7/02/07 1,000 15.16 15,164.30 7/05/07 1,300 15.17 19,725.16 7/06/07 100 15.36 1,536.20 7/10/07 2,000 15.27 30,540.60 7/11/07 2,100 15.19 31,893.75 7/17/07 1,300 15.18 19,738.29 7/18/07 400 15.05 6,019.16 4/11/08 2,600 5.67 14,747.46 4/14/08 5,800 5.64 32,712.58 4/15/08 2,100 5.54 11,624.13 4/16/08 2,500 5.54 13,858.75 4/17/08 9,200 6.39 58,804.56 4/30/08 1,000 6.62 6,624.70 5/01/08 500 6.63 3,315.30 5/02/08 1,200 6.63 7,598.40 5/05/08 900 6.36 5,723.10 5/06/08 600 6.48 3,885.54 5/07/08 800 6.37 5,099.68 5/08/08 500 6.17 3,083.30 5/09/08 800 6.00 4,796.16 5/12/08 1,600 5.72 9,147.84 5/13/08 1,200 5.87 7,046.88 5/14/08 800 5.70 4,558.16 5/15/08 700 5.56 3,891.93 5/16/08 1,300 5.27 6,855.03 5/19/08 2,900 5.28 15,303.01 5/20/08 2,900 5.23 15,177.73 5/21/08 1,700 5.16 8,769.62 1/27/09 1,900 3.66 6,957.99 1/29/09 100 3.69 369.00 Total 74,700 724,169.45 |
FIRST BIOMED, L.P.
Date Shares Cost/Unit Total Cost ---- ------ --------- ---------- 6/15/07 103,200 15.56 1,606,111.92 6/18/07 107,900 15.46 1,667,954.80 6/19/07 52,600 15.48 814,437.36 4/11/08 12,100 5.67 68,632.41 4/14/08 27,100 5.64 152,846.71 4/15/08 9,700 5.54 53,692.41 4/16/08 11,800 5.54 65,413.30 4/17/08 43,400 6.39 277,404.12 4/30/08 4,700 6.62 31,136.09 5/01/08 5,200 6.63 34,479.12 5/02/08 11,700 6.63 77,594.40 5/05/08 8,300 6.36 52,779.70 5/06/08 5,700 6.48 36,912.63 5/07/08 7,300 6.37 46,534.58 5/08/08 5,200 6.17 32,066.32 5/09/08 7,800 6.00 46,762.56 5/12/08 15,600 5.72 89,191.44 5/13/08 12,000 5.87 70,468.80 5/14/08 7,800 5.70 44,442.06 5/15/08 7,300 5.56 40,587.27 5/16/08 13,000 5.27 68,550.30 5/19/08 28,600 5.28 150,919.34 5/20/08 28,600 5.23 149,683.82 5/21/08 16,200 5.16 83,569.32 5/30/08 30,800 5.34 164,481.24 6/02/08 19,600 5.34 104,603.24 6/03/08 41,900 5.46 228,949.98 6/04/08 36,000 5.70 205,160.40 9/08/08 182,264 4.81 876,689.84 Total 863,364 7,342,055.48 |
FIRST BIOMED PORTFOLIO, L.P.
Date Shares Cost/Unit Total Cost ---- ------ --------- ---------- 6/15/07 136,800 15.56 2,129,032.08 6/18/07 56,100 15.46 867,161.70 6/19/07 27,400 15.48 424,250.64 10/30/07 2,100 13.76 28,896.21 2/07/08 8,600 12.26 105,453.20 5/30/08 16,200 5.34 86,512.86 6/02/08 10,400 5.34 55,503.76 6/03/08 22,100 5.46 120,758.82 6/04/08 19,000 5.70 108,279.10 |
6/10/08 13,400 5.75 77,088.86 6/11/08 2,800 5.81 16,280.04 6/13/08 11,000 5.85 64,322.50 7/10/08 51,900 5.27 273,544.52 7/11/08 20,000 5.30 105,912.00 7/14/08 6,800 5.42 36,868.92 7/15/08 22,000 5.19 114,208.60 7/16/08 600 5.34 3,205.02 7/22/08 100 5.72 572.00 9/08/08 32,915 4.81 158,321.15 9/08/08 27,600 4.81 132,756.00 Total 487,815 4,908,937.98 |
FIRST HEALTH, L.P.
Date Shares Cost/Unit Total Cost ---- ------ --------- ---------- 6/20/07 64,300 15.48 995,646.92 6/21/07 64,300 15.25 980,735.75 6/25/07 8,000 14.96 119,644.80 6/26/07 12,800 14.95 191,407.36 6/27/07 12,900 14.88 191,921.04 6/29/07 19,300 15.04 290,233.40 7/02/07 7,241 15.16 109,804.70 7/05/07 10,600 15.17 160,835.92 7/06/07 800 15.36 12,289.60 7/10/07 16,000 15.27 244,324.80 7/11/07 16,100 15.19 244,518.75 7/17/07 10,300 15.18 156,387.99 7/18/07 3,500 15.05 52,667.65 4/11/08 20,300 5.67 115,143.63 4/14/08 45,450 5.64 256,342.55 4/15/08 16,200 5.54 89,671.86 4/16/08 19,700 5.54 109,206.95 4/17/08 72,400 6.39 462,766.32 4/30/08 7,800 6.62 51,672.66 5/01/08 4,300 6.63 28,511.58 5/02/08 9,600 6.63 63,667.20 5/05/08 6,800 6.36 43,241.20 5/06/08 4,700 6.48 30,436.73 5/07/08 5,900 6.37 37,610.14 5/08/08 4,300 6.17 26,516.38 5/09/08 6,400 6.00 38,369.28 5/12/08 12,800 5.72 73,182.72 5/13/08 9,800 5.87 57,549.52 5/14/08 6,400 5.70 36,465.28 5/15/08 6,000 5.56 33,359.40 5/16/08 10,700 5.27 56,422.17 5/19/08 23,500 5.28 124,007.15 5/20/08 23,500 5.23 122,991.95 5/21/08 13,300 5.16 68,609.38 1/27/09 2,800 3.66 10,253.88 1/29/09 1,400 3.69 5,166.00 Total 580,191 5,691,582.61 |
FIRST HEALTH LIMITED
Date Shares Cost/Unit Total Cost ---- ------ --------- ---------- 6/20/07 27,600 15.48 427,369.44 6/21/07 27,600 15.25 420,969.00 6/25/07 3,500 14.96 52,344.60 6/26/07 5,500 14.95 82,245.35 6/27/07 5,500 14.88 81,826.80 6/29/07 8,300 15.04 124,815.40 7/02/07 3,100 15.16 47,009.33 7/05/07 4,500 15.17 68,279.40 7/06/07 300 15.36 4,608.60 7/10/07 7,000 15.27 106,892.10 7/11/07 6,800 15.19 103,275.00 7/17/07 4,400 15.18 66,806.52 7/18/07 1,500 15.05 22,571.85 1/23/08 6,900 12.43 85,779.42 1/24/08 8,300 12.69 105,332.81 1/25/08 6,900 12.36 85,258.47 1/28/08 14,900 12.25 182,569.70 1/29/08 9,700 12.48 121,052.12 1/30/08 3,400 12.61 42,872.30 2/01/08 2,700 12.65 34,141.50 2/04/08 300 12.66 3,798.00 2/05/08 6,900 12.42 85,698.69 8/07/08 189,900 5.44 1,033,056.00 Total 355,500 3,388,572.40 |
1 Year Aspect Medical Systems (MM) Chart |
1 Month Aspect Medical Systems (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
